Yüklüyor......
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores
BACKGROUND & AIMS: It is unclear if hepatocellular carcinoma (HCC) risk declines over time after hepatitis C virus (HCV) eradication. We analyzed changes in HCC annual incidence over time following HCV eradication and identified dynamic markers of HCC risk. METHODS: We identified 48,135 patients...
Kaydedildi:
| Yayımlandı: | Gastroenterology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6815714/ https://ncbi.nlm.nih.gov/pubmed/31356807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2019.07.033 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|